サンプル依頼リスト カート
  • English
  • Korean
デフォルト表紙
市場調査レポート
商品コード
1760994

腫瘍栄養学の世界市場

Oncology Nutrition

出版日
ページ情報
英文 352 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=148.47円
腫瘍栄養学の世界市場
出版日: 2025年07月02日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 352 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

腫瘍栄養学の世界市場は2030年までに25億米ドルに達する

2024年に15億米ドルと推定される腫瘍栄養学の世界市場は、2024年から2030年にかけてCAGR 9.6％で成長し、2030年には25億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである頭頸部は、CAGR 8.5%を記録し、分析期間終了時には6億960万米ドルに達すると予測されています。胃・消化器セグメントの成長率は、分析期間でCAGR 11.7％と推定されます。

米国市場は5億2,190万米ドルと推定、中国はCAGR11.5％で成長予測

米国の腫瘍栄養学市場は、2024年には5億2,190万米ドルと推定されます。世界第2位の経済大国である中国は、2030年までに2億5,450万米ドルの市場規模に達すると予測され、分析期間2024-2030年のCAGRは11.5%です。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ8.4%と7.9%と予測されています。欧州では、ドイツがCAGR約9.3%で成長すると予測されています。

世界の腫瘍栄養学市場- 主要動向と促進要因まとめ

腫瘍栄養学とは何か、なぜ重要なのか？

腫瘍栄養学は、がん患者特有の食事ニーズを満たすことに焦点を当て、症状の管理と治療成績の向上を支援します。がんやその治療は、患者の食事能力や栄養吸収能力に大きな影響を与えるため、栄養はがん治療において極めて重要な役割を果たします。適切な栄養ケアは、体力の維持、感染リスクの低減、生活の質の向上、回復率の向上に役立ちます。特定の栄養欠乏に対処し、吐き気や体重減少などの治療副作用を管理し、治療中および治療後の身体の免疫系と全体的な健康をサポートする、個別化された食事計画が含まれます。

調査は腫瘍栄養学の実践にどのような影響を与えていますか？

腫瘍栄養学の継続的な調査により、特定の食品や栄養素が腫瘍の成長、患者の回復力、治療効果にどのように影響するかについての理解が深まっています。治療により、化学療法による吐き気や放射線による体重減少など、がん治療の副作用を軽減できる特定の栄養戦略が特定されています。例えば、オメガ3脂肪酸はがん患者の筋肉量を維持するのに役立つことが分かっており、果物や野菜に含まれる抗酸化物質は化学療法による酸化ストレスを軽減する可能性があります。このような研究開発の積み重ねは、がん治療におけるより効果的でエビデンスに基づいた栄養ガイドラインや介入の開発を支えています。

腫瘍栄養学においてヘルスケア専門家はどのような役割を果たすのか？

がん専門医、栄養士、栄養スペシャリストなどのヘルスケア専門家は、がんケアに栄養を統合する上で重要な役割を果たしています。彼らは協力して患者の栄養状態を評価し、オーダーメイドの栄養計画を立案し、治療の進行に応じてこれらの計画を調整します。これらの専門家が提供する教育は、がん治療中の食事の選択や食習慣について患者や介護者が十分な情報を得た上で決定できるようにするために不可欠です。彼らの専門知識により、栄養戦略が安全かつ効果的に治療目標に沿ったものとなるため、患者の転帰と栄養勧告の遵守が最適化されます。

腫瘍栄養学市場の成長を促すものは何か？

腫瘍栄養学市場の成長は、世界のがん罹患率の上昇、栄養とがん回復の関連性に対する意識の高まり、栄養調査の進歩など、いくつかの要因によってもたらされます。世界人口の高齢化に伴い、がん患者の数は増加の一途をたどっており、がん患者をサポートするための専門的な栄養戦略に対する需要が高まっています。さらに、食事が治療効果や患者のQOLにどのような影響を及ぼすかについて患者や医療提供者の認識が深まるにつれて、がんの治療計画全体に合わせた栄養ケアを組み込むことが重視されるようになっています。栄養評価ツールの技術的進歩や栄養に焦点を当てた調査への投資の増加が市場の成長をさらに後押しし、効果的な実践方法の理解と実施が強化されています。

セグメント

がん種（頭頸部、胃・消化器、膵臓、乳房、肝臓、その他のがん種）;エンドユーザー（病院、在宅ケア、その他のエンドユーザー）

調査対象企業の例（計31社に注目）

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Koninklijke DSM N.V.
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Aceto Corporation
  • Meiji Holdings Co., Ltd.
  • Nestle Health Science SA
  • Mead Johnson & Company, LLC.
  • Nutricia BV
  • Alniche Life Sciences Pvt., Ltd.
  • Global Health Products, Inc.
  • Pristine Organics Pvt. Ltd.
  • Hexagon Nutrition

AI統合

Global Industry Analystsは、有効な専門家コンテンツとAIツールにより、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • スペイン
  • ロシア
  • その他欧州
  • アジア太平洋
  • オーストラリア
  • インド
  • 韓国
  • その他アジア太平洋地域
  • ラテンアメリカ
  • アルゼンチン
  • ブラジル
  • メキシコ
  • その他ラテンアメリカ
  • 中東
  • イラン
  • イスラエル
  • サウジアラビア
  • アラブ首長国連邦
  • その他中東
  • アフリカ

第4章 競合

目次
Product Code: MCP13705

Global Oncology Nutrition Market to Reach US$2.5 Billion by 2030

The global market for Oncology Nutrition estimated at US$1.5 Billion in the year 2024, is expected to reach US$2.5 Billion by 2030, growing at a CAGR of 9.6% over the analysis period 2024-2030. Head & Neck, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$609.6 Million by the end of the analysis period. Growth in the Stomach & Gastrointestinal segment is estimated at 11.7% CAGR over the analysis period.

The U.S. Market is Estimated at US$521.9 Million While China is Forecast to Grow at 11.5% CAGR

The Oncology Nutrition market in the U.S. is estimated at US$521.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$254.5 Million by the year 2030 trailing a CAGR of 11.5% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 8.4% and 7.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 9.3% CAGR.

Global Oncology Nutrition Market - Key Trends & Drivers Summarized

What Is Oncology Nutrition and Why Is It Critical?

Oncology nutrition focuses on meeting the unique dietary needs of cancer patients to help manage symptoms and improve treatment outcomes. Nutrition plays a pivotal role in oncology because cancer and its treatments can significantly affect the patient's ability to eat and absorb nutrients. Proper nutritional care can help maintain body strength, decrease infection risks, improve quality of life, and enhance recovery rates. It involves personalized diet plans that address specific nutritional deficiencies, manage treatment side effects like nausea and weight loss, and support the body’s immune system and overall health during and after treatment.

How Does Research Influence Oncology Nutrition Practices?

Continuous research in oncology nutrition has deepened understanding of how certain foods and nutrients affect tumor growth, patient resilience, and treatment response. Studies have identified specific nutritional strategies that can mitigate the side effects of cancer treatments, such as chemotherapy-induced nausea or radiation-induced weight loss. For instance, omega-3 fatty acids are found to help preserve muscle mass in cancer patients, while antioxidants in fruits and vegetables may reduce the oxidative stress caused by chemotherapy. This growing body of research supports the development of more effective, evidence-based nutritional guidelines and interventions for cancer care.

What Role Do Healthcare Professionals Play in Oncology Nutrition?

Healthcare professionals, including oncologists, dietitians, and nutrition specialists, play a crucial role in integrating nutrition into cancer care. They work collaboratively to assess the nutritional status of patients, devise customized nutrition plans, and adjust these plans as treatment progresses. Education provided by these professionals is vital, as it empowers patients and caregivers to make informed decisions about food choices and dietary habits during cancer treatment. Their expertise ensures that nutritional strategies are safely and effectively aligned with therapeutic goals, thereby optimizing patient outcomes and adherence to nutrition recommendations.

What Drives the Growth in the Oncology Nutrition Market?

The growth in the oncology nutrition market is driven by several factors, including rising global cancer incidence rates, growing awareness of the link between nutrition and cancer recovery, and advancements in nutritional research. As the global population ages, the number of cancer cases continues to climb, increasing the demand for specialized nutritional strategies to support oncology patients. Moreover, as patients and healthcare providers become more aware of how diet impacts treatment efficacy and patient quality of life, there is a greater emphasis on integrating tailored nutritional care into overall cancer treatment plans. Technological advancements in nutritional assessment tools and increased investment in nutrition-focused research further fuel market growth, enhancing the understanding and implementation of effective oncology nutrition practices.

SCOPE OF STUDY:

The report analyzes the Oncology Nutrition market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Cancer Type (Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver, Other Cancer Types); End-Use (Hospitals, Home Care, Other End-Uses)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.

Select Competitors (Total 31 Featured) -

  • Abbott Laboratories, Inc.
  • B. Braun Melsungen AG
  • Koninklijke DSM N.V.
  • Baxter International, Inc.
  • Fresenius Kabi AG
  • Fresenius SE & Co. KGaA
  • Aceto Corporation
  • Meiji Holdings Co., Ltd.
  • Nestle Health Science SA
  • Mead Johnson & Company, LLC.
  • Nutricia BV
  • Alniche Life Sciences Pvt., Ltd.
  • Global Health Products, Inc.
  • Pristine Organics Pvt. Ltd.
  • Hexagon Nutrition

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Tariff Impact on Global Supply Chain Patterns
    • Oncology Nutrition - Global Key Competitors Percentage Market Share in 2025 (E)
    • Global Economic Update
    • Cancer - Food choices, Dietary habits and Cancer risk
    • Significance of Proper Nutrition for Cancer Patients
    • What to Eat in Cancer
    • Importance of Adequate Nutrition during Cancer Treatment
    • Nutrition During Cancer Treatment
    • Common Causes of Nutrition and Malnutrition in Cancer Patients
    • Cancer Treatment Side Effects that are Likely to Cause Dehydration and Malnutrition
    • Commercial Feeding Formulas
    • Factors to be Considered When Selecting a Particular Formula
    • Global Market Analysis and Prospects
    • Global Oncology Nutrition Market Witnesses Rapid Growth
    • Developed Regions Account for Major Share, Developing Regions Witness Rapid Growth
    • Competition
    • Recent Market Activity
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Global Incidence of Cancer Drives the Oncology Nutrition Market
    • Global Cancer Incidence: Number of New Cancer Cases in Million for the Years 2018, 2020, 2025, 2030, 2035 and 2040
    • Rising Number of Malnourished Cancer Patients Drive the Demand for Oncology Nutrition Market
    • Patient Diagnosis with Malnutrition
    • Post Treatment Duration and Nutrition for Advanced Cancer
    • Meeting Nutritional Needs of Cancer Patients
    • Nutrition for Breast Cancer Survivorship
    • Introduction of Nutrient-Rich Oncology Nutritional Supplements Ensure Quick Recovery for Cancer Patients
    • Ongoing Research and Development Initiatives Fuel Demand for Oncology Nutrition Products
    • Demand for Gluten and Lactose-Free Enteral Nutrition Formulas Exhibits an Upward Momentum
    • Launch of New Nutritional Products for Cancer Patients
    • Diet for Colon Cancer Surgery
    • Ageing Demographics to Drive Market Demand
    • Global Aging Population Statistics for the 65+ Age Group in Million by Geographic Region for the Years 2019, 2025, 2035 and 2050
    • Elderly Population (65+ Years) as a % of Total Population by Developed, Less Developed and Least Developed Regions: 2019 & 2030
    • Uptrend in Healthcare Spending Drives Market Demand
    • Enteral Nutrition Market to Remain Buoyant and Strong
    • Oncology Applications Leads EN Market
    • Shift towards Home Care Boosts Demand for Clinical Nutrition Products
    • Changing Health and Social Care Factors Favor Home Enteral Feeding
    • Increasing Popularity of Intravenous Vitamin C for Cancer Treatment
    • Shift towards Enteral Nutrition Therapies - A Threat to Parenteral Nutrition Market
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Head & Neck by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Head & Neck by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Stomach & Gastrointestinal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Stomach & Gastrointestinal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Pancreatic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Pancreatic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Breast by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Breast by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Liver by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Liver by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Other Cancer Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Other Cancer Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 21: World 15-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 23: World Historic Review for Home Care by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 24: World 15-Year Perspective for Home Care by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 25: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 26: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 27: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 28: World Oncology Nutrition Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 29: World Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 30: World Historic Review for Oncology Nutrition by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: World 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 32: USA Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 35: USA Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: USA Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: USA 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 41: Canada Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Canada Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: Canada 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 47: Japan Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Japan Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Japan 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 50: China Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 53: China Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: China Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: China 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 62: Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 63: Europe Historic Review for Oncology Nutrition by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Europe 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 65: France Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 68: France Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: France Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: France 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 74: Germany Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Germany Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: Germany 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 80: Italy Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Italy Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Italy 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 83: UK Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 86: UK Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: UK Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: UK 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 92: Spain Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Spain Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Spain 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 98: Russia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Russia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 100: Russia 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Rest of Europe Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 106: Rest of Europe 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 113: Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 114: Asia-Pacific Historic Review for Oncology Nutrition by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 115: Asia-Pacific 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • AUSTRALIA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 119: Australia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: Australia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 121: Australia 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 122: India Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 125: India Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: India Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 127: India 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 131: South Korea Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: South Korea Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 133: South Korea 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 137: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Rest of Asia-Pacific Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 139: Rest of Asia-Pacific 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 146: Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 147: Latin America Historic Review for Oncology Nutrition by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 148: Latin America 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 152: Argentina Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Argentina Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 154: Argentina 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 158: Brazil Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Brazil Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 160: Brazil 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 164: Mexico Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Mexico Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 166: Mexico 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 170: Rest of Latin America Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Rest of Latin America Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 172: Rest of Latin America 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
    • TABLE 179: Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 180: Middle East Historic Review for Oncology Nutrition by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 181: Middle East 15-Year Perspective for Oncology Nutrition by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • IRAN
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 185: Iran Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Iran Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 187: Iran 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 191: Israel Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Israel Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 193: Israel 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 197: Saudi Arabia Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Saudi Arabia Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 199: Saudi Arabia 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 203: UAE Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: UAE Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 205: UAE 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 209: Rest of Middle East Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Rest of Middle East Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 211: Rest of Middle East 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Oncology Nutrition Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Oncology Nutrition by Cancer Type - Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Oncology Nutrition by Cancer Type - Percentage Breakdown of Value Sales for Head & Neck, Stomach & Gastrointestinal, Pancreatic, Breast, Liver and Other Cancer Types for the Years 2015, 2025 & 2030
    • TABLE 215: Africa Recent Past, Current & Future Analysis for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 216: Africa Historic Review for Oncology Nutrition by End-Use - Hospitals, Home Care and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 217: Africa 15-Year Perspective for Oncology Nutrition by End-Use - Percentage Breakdown of Value Sales for Hospitals, Home Care and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION